Abstract

We sought to determine if an online continuing medical education (CME) curriculum could improve the clinical knowledge and competence of primary care physicians (PCPs) and diabetologists/endocrinologists (diabs/endos) regarding cardiometabolic management of T2D incorporating recent cardiovascular outcomes trial (CVOT) data. The online CME activities consisted of a 2 faculty, 15-minute video consultation and an interactive, case-based text activity. A 4-question repeated pairs pre-/post-assessment study design and McNemar’s chi-squared test were used to determine the efficacy of online education. P values < .are considered statistically significant. Activities were launched online on June 26, 2017 and August 28, 2017, with data collected until July 27, 2017 and September 28, 2017, respectively.PCPs baseline knowledge seen to be significantly lower than that of diabs/endosTopicPCP Baseline Correct ResponsesDiab/endo Baseline Correct ResponsesP valueAvoidance of TZDs in patent with T2D and HF36% (N=344)71% (N=41)P < 0.001Optimizing T2D therapy to meet cardiac-related goals47% (N=344)78% (N-41)P < 0.001T2D treatment intensification in patient with CVD25% (N=344)54% (N=41)P < 0.001Identification of blood pressure lowering as an extraglycemic effect of SGLT2 inhibitors49% (N=200)81% (N=78)P < 0.001Significant overall improvements were seen post educationTopicPCP Change pre-to-postP valueDiab/endo Change pre-to-postP valueSelection of liraglutide to treat a patient with T2D, CVD, and renal disease51% (N=344)P<.000139% (N=41)P<.0001Recognition of TZDs as a bad therapeutic option in a patient with T2D and HF27% (N=344)P<.000114% (N=41)P=.114Identification of antihyperglycemic agents that have been shown to have positive CV effects16% (N=200)P<.00118% (N=78)P=.006Recognized blood pressure lowering as an extraglycemic effect of SGLT2 inhibitors13% (N=200)P<.00114% (N=78)P=.003Persistent knowledge/competence gapsTopicPCP Gap (Percent incorrect)Diab/endo Gap (Percent incorrect)Knowledge of CVOT data40% (N=344)37% (N=41)Therapeutic intensification strategy for T2D and CVD39% (N=344)15% (N=41)Utilization of TZDs in patent with T2D and HF37% (N=344)15% (N=41)Knowledge of CVOT data40% (n=200)37% (N=78)Efficacy of antihyperglycemia therapies24% (n=200)14% (N=78) This study demonstrates the success of an online curriculum with multiple educational components consisting of both video discussions and interactive text-based cases improving knowledge and competence of PCPs and diab/endos. Additional and persistent gaps were identified for future educational targets. Disclosure A. Larkin: None. M. LaCouture: None. A. Le: None.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call